- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/133 - Amines, p. ex. amantadine ayant des groupes hydroxyle, p. ex. sphingosine
Détention brevets de la classe A61K 31/133
Brevets de cette classe: 553
Historique des publications depuis 10 ans
|
50
|
41
|
50
|
54
|
62
|
62
|
53
|
55
|
28
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Insmed Incorporated | 231 |
16 |
| NeuroDerm, Ltd. | 135 |
11 |
| The Cleveland Clinic Foundation | 1575 |
10 |
| The Regents of the University of California | 19812 |
9 |
| Dyve Biosciences, Inc. | 31 |
8 |
| OCuSOFT, Inc. | 154 |
6 |
| University of Virginia Patent Foundation | 1563 |
6 |
| The Johns Hopkins University | 5642 |
5 |
| Ortho-nutra, LLC | 14 |
5 |
| Vanda Pharmaceuticals, Inc. | 352 |
5 |
| Metanoi Therapeutics, Inc. | 6 |
5 |
| Adjuvant Holdings Co.,Ltd. | 20 |
5 |
| Conopco, Inc. | 4952 |
4 |
| Janssen Pharmaceutica N.V. | 3423 |
4 |
| University of Florida Research Foundation, Inc. | 3989 |
4 |
| Hikma Pharmaceuticals LLC | 11 |
4 |
| Hovione Scientia Limited | 132 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
4 |
| Emerald Health Pharmaceuticals Inc. | 14 |
4 |
| Glaxosmithkline Intellectual Property Development Limited | 753 |
3 |
| Autres propriétaires | 431 |